Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population

Medicina

Volumn 61, Issue 3, 2001, Pages 279-283

  Krochik, A G ^a   Mazza, C S ^a   Valdez, S N ^a   Stumpo, R R ^a   Papouchado, M L ^a   Iacono, R F ^a   Cardoso Landaburu, A C ^a   Sica, M P ^a   Ozuna, B ^a   Poskus, E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Autoantibodies; Glutamic acid decarboxylase antibodies; HLA; ICA; ICA512 antibodies; Insulin autoantibodies; Type 1 diabetes mellitus

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; AGE; ALLELE; ARGENTINA; ARTICLE; CHILD; CONTROLLED STUDY; EVALUATION; FEMALE; GENETIC MARKER; GENOTYPE; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POPULATION; PREDICTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SIBLING;

ADOLESCENT; ADULT; ARGENTINA; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC MARKERS; GLUTAMATE DECARBOXYLASE; HLA ANTIGENS; HUMANS; INFANT; ISLETS OF LANGERHANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 0034761412     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Establishment of a registry and incidence of IDDM in Avellaneda, Argentina
2. Prevention of diabetes in the NOD mouse: Implications for therapeutic intervention in human disease
3. A trial of nicotinamide in newly diagnosed patients with Type 1 (insulin-dependent) diabetes mellitus
4. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
5. Immunogenetics and IDDM
6. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
7. Antiglutamate decarboxylase and other antibodies at the onset of childhood IDDM: A population-based study
8. Glutamate decarboxylase, insulin and islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children
9. Islet autoantibody markers in IDDM: Risk assessment strategies yielding high sensitivity
10. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes
11. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
12. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type 1 diabetes
13. Comparison of GAD and ICA512/IA2 antibodies at and after the onset of IDDM
14. Evaluation of ICA512 in combination with other islet cell autoantibodies at the onset of IDDM
15. HLA DQA1 and DQB1 alleles in IDDM patients of an Argentinian Caucasian population
16. Associations of GAD65 and IA2 autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings
17. Prediction of Type 1 Diabetes
18. HLA-DQ screening for risk assessment of insulin dependent diabetes in northern Italy
19. What causes diabetes
20. Pathogenesis of Childhood Diabetes
21. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512/IA2 autoantibodies
22. Combined screening for autoantibodies to IA2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM
23. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type1 diabetes mellitus: Frequency and segregation by age and gender
24. Associations of GAD antibodies with islet cell antibodies and insulin autoantibodies in first degree relatives of type 1 diabetic patients